Onc.AI, a digital health company developing advanced AI-driven clinical management solutions for oncology, today announced that findings from a recent collaboration with global biopharma company GSK ...

OP-3136 showed activity that was independent of KAT6 amplification or over expression. In the OVCAR3 model, OP-3136 monotherapy demonstrated sustained tumor regression across the 28-day study period ...

TAL61 demonstrated significant anti-tumor properties with strong tolerability in patient-derived xenograft models of chordoma TAL61 showed robust single-agent activity in Brachyury-positive non-small ...

Experiments in mice infected with the SARS-CoV-2 virus revealed that the immune cell class in question, called nerve and ...

A study by former Junior Associate Professor Kazuo Takayama, currently a professor of the Institute of Science Tokyo, ...